XML 32 R17.htm IDEA: XBRL DOCUMENT
v3.26.1

Marketable Securities | 12 Months Ended
--- | ---
Dec. 31, 2025
Investments, All Other Investments [Abstract] |
Marketable Securities | Note 5: Marketable Securities The Company classifies and accounts for its marketable debt securities as AFS and the securities are stated at fair value in accordance with ASC 326, Financial Instruments - Credit Losses. The investments in marketable securities had an adjusted cost basis of $4 million and a market value of $4 million as of December 31, 2025. The balances consisted of the following securities (in thousands):
Schedule of marketable securities |  |  |  |  |  |  |  |  |  |  |  |
|  | Amortized Cost |  |  | Unrealized Gain/(Loss) |  |  | Fair Value |
U.S. Treasury |  | $ | 3,953 |  |  | $ | 25 |  |  | $ | 3,978 |
Total |  | $ | 3,953 |  |  | $ | 25 |  |  | $ | 3,978 |
The investments in marketable securities as of December 31, 2024 had an amortized cost basis of $2.1 million and a market value of $2.0 million. The balances consisted of the following securities (in thousands):
|  | Amortized Cost |  |  | Unrealized Gain/(Loss) |  |  | Fair Value |
Corporate Bonds |  | $ | 559 |  |  | $ | (22 | ) |  | $ | 537 |
U.S. Agency and Government Sponsored Securities |  |  | 1,155 |  |  |  | (48 | ) |  |  | 1,107 |
U.S. States and Municipalities |  |  | 402 |  |  |  | (17 | ) |  |  | 385 |
Total |  | $ | 2,116 |  |  | $ | (87 | ) |  | $ | 2,029 |
The Company holds two AFS securities, all of which were in an unrealized gain position and none had been in an unrealized loss position for a period longer than 12 months as of December 31, 2025. The AFS securities held by the Company as of December 31, 2024 had been in an unrealized loss position for a period greater than 12 months. The Company reported the net unrealized losses in accumulated other comprehensive loss, a component of stockholders’ equity. As of December 31, 2025 and December 31, 2024, an allowance for credit loss was not recognized as the issuers of the securities had not established a cause for default, various rating agencies had reaffirmed each security's investment grade status and the Company did not have the intent, nor is it required to sell its securities prior to recovery. Realized losses of $36,674 and $0.6 million were recognized in earnings during the years ended December 31, 2025 and December 31, 2024, respectively, primarily due to selling securities prior to maturity to prevent further market condition losses on the securities. The contractual maturities of the Company’s marketable investments as of December 31, 2025 were as follows (in thousands):
Schedule of contractual maturities of marketable investments |  |  |  |
|  | Fair Value |
Due within 1 year |  | $ | 3,978 |
Total |  | $ | 3,978 |
The Company may sell certain of its marketable debt securities prior to their stated maturities for reasons including, but not limited to, managing liquidity, credit risk, duration and asset allocation.

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/825/tableOfContent + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration